发明名称 |
RECOMBINANT FACTOR VIII FORMULATIONS |
摘要 |
Provided are liquid and lyophilized recombinant Factor VIII formulations, including formulations for polymer-conjugated FVIII such as PEGylated Factor VIII. |
申请公布号 |
US2016030524(A1) |
申请公布日期 |
2016.02.04 |
申请号 |
US201414774191 |
申请日期 |
2014.03.11 |
申请人 |
BAYER HEALTHCARE LLC |
发明人 |
WANG De Qian;MA Xinghang;TSVETKOVA Nelly |
分类号 |
A61K38/37;A61K47/02;A61K47/22;A61K47/48 |
主分类号 |
A61K38/37 |
代理机构 |
|
代理人 |
|
主权项 |
1. A rFVIII formulation comprising:
(a) a range of from about 1 mM to about 5 mM divalent cation; (b) a range of from about 150 mM to about 250 mM sodium chloride or potassium chloride; (c) a range of from about 50 ppm to about 200 ppm of a non-ionic surfactant; and (d) a range of from about 100 IU/ml to about 5000 IU/ml of a rFVIII, wherein the rFVIII comprises an amino acid sequence that has one or more non-cysteine residues in the amino acid sequence of SEQ ID NO: 3 replaced with cysteine residues such that at least one pair of cysteine residues creates a disulfide bond not found in wild type FVIII; wherein the rFVIII formulation has a pH in a range of from about pH 6.0 to about pH 7.5. |
地址 |
Whippany NJ US |